PRISM MEDICO AND PHARMACY LTD Q3 RESULTS
Tata Consumer shares drop over 2% as Q1 results fail to impress. Should you invest?
Tata Consumer Products reported an 8% drop in profit after tax for the first quarter ended June 2024, falling to Rs 290 crore, below estimates. Shares fell 2.3%. Revenue from operations increased 16% year-on-year to Rs 4,352 crore. The drop in profit was attributed to higher exceptional items and lower returns from joint ventures and associates.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Prism Johnson Q4 Results: Firm posts loss hurt by lower pricing in cement business
Net sales fell marginally to 20.46 billion rupees from 20.56 billion rupees a year ago. Revenue from Prism Johnson's largest segment, cement, declined 3.3%. Cement makers usually resort to price cuts in the March-quarter to boost sales volumes, in order to clear year-end inventory backlogs.
Apollo Hospitals Q3 Results: Net profit rises 60% YoY to Rs 245 crore
Apollo Hospitals on Thursday reported a 60% year-on-year (YoY) jump in net profit to Rs 245 crore in Q3FY24, led by growth across hospital, diagnostics, speciality and pharmacies businesses.
Apollo Hospitals Q3 Results: Cons PAT soars 59% YoY to Rs 245 crore; dividend declared at Rs 6/share
Apollo Hospitals' revenue from operations grew 14% YoY to Rs 4,851 crore, and topped the estimated Rs 4,771 crore. The healthcare services business saw a healthy 13% YoY growth in revenue during the quarter to Rs 2,483 crore, followed by the pharmacy distribution business housed under Apollo Pharmacy, which registered 17% growth in revenue to Rs 2,049 crore.
Hot Stocks: 3 concerns behind $13 bn rout in HDFC Bank; brokerages downgrade LTIMindtree
Brokerage firm Bernstein maintained an outperform rating on HDFC Bank, Nomura maintained a buy rating on Apollo Hospitals, InCred downgraded LTIMindtree and Goldman Sachs maintained a neutral rating on Asian Paints.
- Go To Page 1
Q2 results tomorrow: What to expect from Apollo Hospitals, Adani Ports, ZEE and Samvardhana Motherson
Apollo Hospitals is expected to post 9% growth year-on-year in its net profit while revenues are seen rising 14% year-on-year, according to Nuvama Equities.
Apollo Hospitals Q1 Results: Profit tumbles 47% YoY to Rs 173 crore; revenue up 16%
Revenue from operations during the first quarter, however, rose 16% YoY to Rs 4,418 crore. The same stood at Rs 3,796 crore in the year-ago quarter.
Q1 results this week: Adani Enterprises, SBI, Maruti, Titan, Airtel, M&M & others
Major firms such as Maruti Suzuki, Titan, Bharti Airtel, and M&M among others will release their June quarter results this week. The report cards of other companies such as GAIL, Power Grid, Sun Pharma, and Adani Enterprises are also expected to be out. This week, Maruti Suzuki, Adani Enterprises, Adani Transmission, Titan, IndiGo, Bharti Airtel, Sun Pharma, SBI, M&M, Varun Beverages, and Bank of Baroda are scheduled to announce their quarterly performance.
Ahead of Market: 10 things that will decide D-Street action on Tuesday
Indian equities were supported by strong buying in heavyweight Reliance Industries stocks, which helped the Nifty defend the support of 19,300 and end at 19,356 on Monday. However, broader markets saw losses as IT stocks underperformed, leading to weakness. Meanwhile, analysts are keeping a close eye on the upcoming
Q4 results today: What to expect from Adani Ports & Apollo Hospitals
Adani Ports is expected to register a 31% growth in revenues to Rs 5,028 crore with an 80% profit rise to Rs 1,842 crore in their quarter four report. However, continuing export curbs may impact underlying comparable volume growth in the company. Meanwhile, Apollo Hospitals is set to see its net profit more than double YoY to Rs 241 crore, with sales expected to grow 25%. The growth is expected to come from store additions and higher sales from already established stores.
Building entry barriers in fintech; and other top tech & startup stories this week
The free run that Indian fintech founders had is a thing of the past. Not only has the regulator stepped in to check the speed of innovation, banks are also looking to work only with regulated fintechs.
Stocks in news: DMart, Adani Enterprises, DLF, Tata Motors, PVR
Adani Enterprises and Adani Transmission today announced that they would raise funds totalling Rs 21,000 crore through the qualified institutional placement (QIP) route.
DMart Q4 Results: Net profit rises 8% YoY to Rs 505 crore; misses estimates
Avenue Supermarts, the company that operates the DMart chain of stores, posted a 21.11% YoY jump in revenue to Rs 10,337.12 crore. DMart's margins declined, said CEO and MD Neville Noronha. "Lower consumer spending in general merchandise and apparel continues and has impacted the margin mix downwards," he added. E-commerce expansion continued in the firm's existing 22 cities and expanded to an additional 10 new locations during the year, totalling 324 stores.
Gujarat Board Results 2023: GSEB Class 12 result Date and Time released for Science Stream, check details
The GSEB 2023 Class 12 result will be released on May 2 at the official website gseb.org.
Nykaa reports 68% fall in Q3 profit at Rs 9 crore; Big Tech battle it out for AI control
Nykaa's revenue from operations surged 33% to Rs 1,462 crore for the quarter under review. Revenues in the year-ago quarter stood at Rs 1,098 crore. Expenses surged 36% to Rs 1,455 crore in the December quarter against Rs 1,067 crore in the same period last year.
DMart shares crack 6% after Q3 results: Should you buy, sell or hold?
In Q3, DMart missed estimates by reporting a revenue growth of 25.5%. Its PAT (profit after tax) grew 7% YoY as weak discretionary demand pulled down same store sales growth. Its gross margins declined 60 basis points YoY and 20 basis points QoQ to 14.3%.
Wallmart Q3 Results: Company posts $1.8 billion loss after settlement resolving allegations on opioid cases
But its numbers were bogged down by a settlement set to provide $3.1 billion to communities nationwide and "require significant improvements in how Walmart's pharmacies handle opioids," according to a statement by New York Attorney General Letitia James's office.
Apollo Hospitals Q1 Results: Profit falls 35% YoY to Rs 324 crore
Healthcare services vertical clocked a revenue of Rs 2,032.07 crore as compared to Rs 1,941.24 crore in the same period last year, while the clinics segment revenue was lower at Rs 293.01 crore as compared to Rs 309 crore in the year-ago quarter, the company said.
Apollo Hospitals Q4 Results: Net profit drops 46% on one-time provisioning
As part of the restructuring, the Apollo Pharmacy distribution business was re-organized into a 100% subsidiary Apollo HealthCo Ltd along with Apollo 24/7 - the group’s digital healthcare services platform.
Startup dreamers return to IT firms after layoffs; Zomato reports Rs 360 crore net loss in Q4
IT firms have been battling record attrition of late, so startups’ loss is their gain.
Zomato net loss jumps to Rs 360 crore in Q4; Invact Metaversity is in trouble
Total revenue grew to Rs 1,350 crore in Q4 from Rs 750.8 crore in the same quarter in FY21.
Apollo Hospitals Q3 Results: Profit grows 75% to Rs 228 crore
Revenues from operations rose 32 per cent on a YoY to Rs 3639 crore in Q3FY22 compared to Rs 2,760 crore in Q3 FY21.
Nykaa’s Q3 results; Meta concerned about India’s data bill
The parent company of beauty retailer Nykaa, which had a blockbuster IPO in 2021, has reported a 58% year-on-year fall in its consolidated net profit to Rs 29.01 crore for the October-December quarter.
Procter & Gamble Health profit falls by 34 pc to Rs 45 cr in Oct-Dec
The dip in PAT in December quarter is due to higher investments in marketing initiative to support growth in current year and one-time reversal in the base period
Aster DM Q3 Results: Firm posts Rs 36 crore profit
The healthcare provider posted net loss of 8 crore during the same period of the previous year.
Falguni Nayar on Nykaa's bumper listing; Zomato's Q2 results
After a stellar listing on Wednesday, the company was worth more than Rs 1 lakh crore and Nayar's personal fortune ballooned to around Rs 56,000 crore.
Buy Prism Johnson, target price Rs 152: ICICI Securities
Prism Johnson Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 6770.15 Crore) operating in Cement sector.
Apollo Hospitals Q4 results: Co posts net profit of Rs 169 crore
For the fiscal ended March 31, 2021, the company said its consolidated net profit stood at Rs 136.77 crore. It was at Rs 431.80 crore in FY20.
Load More
